IMAGINE will be developing innovative therapies and novel probiotics for Irritable Bowel Syndrome (IBS) and Inflammatory Bowel Disease (IBD). We’ve been patient-driven in setting priorities for this work. We believe IBD and IBS are caused by an immune response to the disturbance in the gut’s microbiome, and we know diet plays a key role in shaping the gut microbiome.